M.-F. Avril

The Cooperative Induction of Hypoxia-Inducible Factor-1α and STAT3 during Hypoxia Induced an Impairment of Tumor Susceptibility to CTL-Mediated Cell Lysis

Network geometry shows evidence sequestration for medical vs. surgical practices: treatments for basal cell carcinoma

A relative value unit–based cost comparison of treatment modalities for nonmelanoma skin cancer: Effect of the loss of the Mohs multiple surgery reduction exemption

The Patient Outcomes of Surgery—Head/Neck (POS-Head/Neck): A new patient-based outcome measure

Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006

Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease

Natural products to drugs: natural product-derived compounds in clinical trials

Crohn's disease

Cytokeratin 20: A Marker For Diagnosing Merkel Cell Carcinoma

Ulcerative colitis

Gambogic acid induces apoptosis by regulating the expression of Bax and Bcl‐2 and enhancing caspase‐3 activity in human malignant melanoma A375 cells

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Atypical and Malignant Glomus Tumors

Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-Q

Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals

Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration

PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation

The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations

Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology

A Historical Overview of Natural Products in Drug Discovery

Antitumor Activity of 3-Ingenyl Angelate

Risk Prediction Models for Incident Primary Cutaneous Melanoma

Natural product and natural product derived drugs in clinical trials

European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies

Chemotherapy in Neuroendocrine/Merkel Cell Carcinoma of the Skin: Case Series and Review of 204 Cases

Evaluation of Cosmetic Results of a Randomized Trial Comparing Surgery and Radiotherapy in the Treatment of Basal Cell Carcinoma of the Face

Influence of Genes, Nevi, and Sun Sensitivity on Melanoma Risk in a Family Sample Unselected by Family History and in Melanoma-Prone Families

Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: relationship to Bcl-2 family and caspase activation

Primary neuroendocrine carcinoma of the skin